Hypolipidemic activity of Prosopis cineraria L (Druce) fruit extract and molecular modeling study with farnesoid X receptor (FXR)

Tropical Journal of Pharmaceutical Research

Volumn 14, Issue 9, 2015, Pages 1621-1628

  Jain, Pankaj G ^a   Surana, Sanjay J ^a  

^a R C PATEL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH   (India)

Author keywords

Anti hyperlipidemic activity; Docking studies; Farnesoid X receptor; Prosopis cineraria; Simvastatin; Triton

Indexed keywords

FARNESOID X RECEPTOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLANT EXTRACT; PROSOPIS CINERARIA FRUIT EXTRACT; SIMVASTATIN; SITOSTEROL; TRIACYLGLYCEROL; TYLOXAPOL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROGENESIS; BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; FRUIT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPERLIPIDEMIA; HYPOLIPEMIA; IC50; LIPID PEROXIDATION; MOLECULAR DOCKING; MOUSE; NONHUMAN; RAT; SINGLE DRUG DOSE;

EID: 84943252677     PISSN: 15965996     EISSN: 15969827     Source Type: Journal    
DOI: 10.4314/tjpr.v14i9.11     Document Type: Article

References (28)

1. WHO Monica project, Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas A, Pajak A. Myocardial infarction and coronary deaths in the World Health Organisation Project. Circulation 1994; 90: 583-612.
2. Bennani-Kabchi N, Fdhil H, Cherrah Y, Kehel L, el Bouavadi F, Amarti A, Saidi M, Marquie G. Effects of Olea europea var. oleaster leaves in hypercholesterolemic insulin-resistant sand rats. Therapie 1999; 54(6): 717-723.
3. Berliner JA, Heinecke JW. The role of oxidized lipoproteins in atherogenesis. Free Radical Biol. Med 1996; 20: 707-727.
4. Gingliano D. Dietary antioxidants for cardiovascular prevention. Nutr Metab Cardiovasc. Dis 2000; 10: 38-44.
5. Anderson JK, Teuber SS, Gobeille A, Cremin P, Waterhouse AL, Steinberg FM. Walnut polyphenolics inhibit in vitro human plasma and LDL oxidation. J Nutr 2000; 131: 2837-2842.
6. Rohilla A, Dagar N, Rohilla S, Dahiya A, Kushnoor A. Hyperlipidemia-a deadly pathological condition. Int J Curr Pharm Res 2012; 4: 15-18.
7. Hemalatha S, Wahi AK, Singh PN, Chansouria JPN. Hypolipidemic Activity of Aqueous Extract of Withania coagulans Dunal in Albino Rats. Phytother Res 2006; 20: 614-617.
8. Umamaheswari M, Asokkumar K, Rathidevi R, Sivashanmugam AT, Subhadradevi V, Ravi TK. Antiulcer and in vitro antioxidant activities of Jasminum grandiflorum L. J Ethnopharmacol 2007; 110: 464-470.
9. Jain PG, Patil SD, Haswani NG, Girase MV, Surana SJ. Hypolipidemic activity of Moringa oleifera Lam., Moringaceae, on high fat diet induced hyperlipidemia in albino rats. Revista Brasileira de Farmacognosia 2010; 20(6): 969-973.
10. Pilaipark C, Panya K, Yupin S, Srichan P, Noppawan PM, Laddawal PN, Piyanee R, Supath S and Klaiupsorn SP. The in vitro and ex vivo antioxidant properties, hypolipidaemic and antiatherosclerotic activities of water extract of Moringa oleifera Lam. Leaves. J. Ethnopharmacol 2008; 116: 439-446.
11. Burkart A. A monograph of genus Prosopis (Leguminous). J Ar Arb 1976; 57: 219-49, 450-525.
12. Shalini. Vedic Leguminous Plants, (Shalini, Ed), Classical publishing co, 1997; pp. 57-80.
13. Toky OP. Medicinal values of Prosopis cineraria in arid and semiarid India. Society of Chemical Industry, I, 1999; pp 1-10.
14. Purohit SD, Ramawat KG, Arya HC. Phenolics, peroxidase and phenolase as related to gall formation in some arid zone plants. Curr Sci 1979; 48: 714-716.
15. Rhoades DF. Herbivores, their interaction with secondary plant metabolites. Acad. Press Inc. London, 1979; pp 3-54.
16. Nahla AH and Farag WT. Design, synthesis and docking studies of new furobenzopyranones and pyranobenzopyranones as photo-reagent towards DNA and as antimicrobial agents. Eur. J. Med. Chem 2010; 45: 317-325.
17. Kokate CK. Practical Pharmacognosy. Vallabh Prakashan, New Delhi, India, 1998; 107-111.
18. Guidance document on acute oral toxicity testing. Series on testing and assessment N0 24.OECD environment, health and safety publications 2001.Accessed from http://www.oecd.org/officialdocuments/publicdisplayd ocumentpdf/?cote=env/jm/mono(2001)4&doclanguag e=en on 18 June 2013.
19. Kourounakis AP, Victoratos P, Peroulis N, Stefanou, Yiangou M, Hadjipetrou L. Experimental Hyperlipidemic and the Effect of NSAIDs. Exper Mol Pathol 2002; 73: 135-138.
20. Friedewald WT, Levy RI, Frederickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge. Clin chem. 1972; 18: 499-502.
21. Muruganandan S, Srivinasan K, Gupta S, Gupta PK, Lal J. Effect of mangiferin on hyperglycemia and atherogenicity in streptozotocin diabetic rats. J Ethnopharmacol 2005; 97: 497-501.
22. Oyaizu M. Studies on products of browing reaction prepared from glucosamine: Jap J Nutri 1986; 44: 307-315.
23. http://www.rcsb.org/pdb/explore.do?structureId=1OSH. Accessed on 23rd October 2013.
24. Zhong H, Tran LM, Stang JL. Induced-fit docking studies of the active and inactive states of protein tyrosine kinases. J. Mol. Graph. Mod 2009; 28: 336-346.
25. Shimazaki H. Antioxidants. In: Niki E, Shimazaki, H, Mino, M (eds). Free radicals and biological defense: Japanese Science Societies Press, Tokyo, 1994; pp 45-57.
26. Bertges LC, Mourǎo Jr CA, Souza JB, Cardoso VA. Hyperlipidemia induced by triton WR 1339 (Tyloxapol) in wistar rats. Rev Bras Cien Med Saūde 2011; 1: 32-34.
27. Otway S, Robinson DS. The use of a non-ionic detergent (triton WR 1339) to determine rates of triglyceride entry into the circulation of the rat under different physiological conditions. J.Physiol 1967; 190: 321-332.
28. Saluja MP, Kapil RS, Popli SP. Studies in medicinal plants: part VI. Chemical constituents of Moringa oleifera Lam. (hybrid variety) and isolation of 4-hydroxymellein. Indian J Chem B 1978; 16B: 1044-1045.